Follow US:
UC Riverside-led national survey of MS specialists finds nearly 10% had been redeployed to the front lines of COVID-19 patient care
Even as vaccinations across the U.S. were ramping up due to the popularity and availability of the one-dose Johnson & Johnson vaccine, the CDC called a timeout due to reports of serious blood clots
PANDORA sequencing method developed by UC Riverside-led team can detect once-undetectable small RNAs
UC Riverside study identified toxic elements in pod atomizers
UC Riverside biomedical scientists were part of an international team that identified the coronavirus strain
Immunity generated by vaccination is better than immunity from an actual infection, says an expert
C OVID-19 is far from beaten. Vaccines may not be the ultimate panacea to haul us out of the pandemic crisis. In the future, will outbreaks of SARS-CoV-2, the virus that causes COVID-19, arrive in waves every winter? Might COVID-19 never go away? Experts at the University of California, Riverside...
UC Riverside-led study examined the effects of the medication risperidone on brain metabolism in stuttering
Severe acne often leaves deep psychological scars, disproportionately affecting women and people with darker skin. Researchers say dermatological treatment isn't enough.
UC Riverside public health expert Richard Carpiano weighs in on ethical matters for vaccine distribution.
UC Riverside-led mouse study stresses MS treatment should be started early
UC Riverside epidemiologist answers this and other questions in Q&A
Dr. David Lo at the UC Riverside School of Medicine is an expert on vaccines
A UC Riverside-led study, funded by Merck, is set to find out
UC Riverside study examines molecular pathways that may instigate seizures in some multiple sclerosis patients
Phase 2 study investigates efficacy of the drug ecopipam developed by Emalex Biosciences Inc.
Meeting virtually with people outside your household is safest, says UC Riverside epidemiologist
Host campus UC Riverside will be joined by UC Davis and UC Merced
Neural crest study results could boost stem cell therapies
The news arrived Monday that the world has been awaiting since spring: a vaccine has been developed that shows a high degree of efficacy in late-stage trials: 90%. That puts it in the company of effective vaccines such as for measles, and well beyond what the medical community hoped for...
